4 min read

EverHint – EMA 10 + Price + MACD, SMA 20/50 Crossover, EMA 10/30 Crossover – Top 12 Buy and Top 10 Sell Signals for Oct 07, 2026

22 signals (from 74 total). Technology leads (14). price range $8-$942. 2 with insider selling.

Excerpt: 22 signals (from 74 total). Technology leads (14). price range $8-$942. 2 with insider selling.

Market Context

Equity markets are exhibiting mild but broad-based weakness, with the Dow Jones underperforming relative to the S&P 500 and Nasdaq, suggesting some rotation away from value and dividend-sensitive names toward growth and technology exposure. The modest declines across all three indices reflect a cautious but not panicked risk environment — conditions that can produce choppy, range-bound price action rather than clean directional trends. For momentum-based strategies like EMA 10 + Price + MACD and EMA 10/30 Crossovers, this type of subdued selling pressure can generate mixed signal quality, as short-term moving averages may whipsaw without sustained follow-through.

The VIX at 15.08, with a slight uptick of 0.47%, remains well within a low-volatility regime, sitting comfortably below the 20 threshold that typically signals elevated market stress. This suppressed volatility environment tends to compress intraday price ranges, which can reduce the amplitude of crossover signals and limit the reward potential on short-term trades. However, it also means false breakouts are less likely to be driven by panic or euphoria, lending slightly more reliability to trend-confirmation signals like the SMA 20/50 Crossover when a genuine directional bias does emerge.

With Technology leading signal generation across all three strategies, the sector's continued dominance aligns with the relative resilience of the Nasdaq compared to the broader Dow. This suggests the market's risk appetite, while tempered, is still tilted toward growth-oriented, higher-multiple sectors. Traders should note that in low-VIX, mildly declining markets, the highest-quality signals will likely come from names with strong underlying momentum rather than those riding broad market tailwinds, making signal selectivity particularly important in the current environment.

EMA 10 + Price + MACD

Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.

Entry Criteria:

  • Buy: Price > EMA10 AND MACD line crosses above signal line
  • Sell: Price < EMA10 AND MACD line crosses below signal line
  • Minimum ADV: $40M (liquidity filter)
  • Earnings buffer: 7 days pre/post earnings
  • Fresh signal: All conditions met on today's close

Holding period: 1-3 weeks | Risk level: Medium-High

🟢 Buy Signals (5 of 10)

Ranked by RSI (lower RSI = more oversold for buy signals)

# Ticker Company Sector Price Insider MCap
1 BCPC Balchem Corp Basic Materials $166.41 — $5.3B
2 BCRX BioCryst Pharmaceutica... Healthcare $8.40 — $2.1B
3 BKV BKV Corporation Energy $23.68 — $2.6B
4 BRO Brown & Brown, Inc. Financial Services $61.72 — $20.7B
5 CVS CVS Health Corp. Healthcare $87.95 — $112.2B

SMA 20/50 Crossover

Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.

Entry Criteria:

  • Buy: SMA20 crosses above SMA50
  • Sell: SMA20 crosses below SMA50
  • Minimum ADV: $40M (liquidity filter)
  • Earnings buffer: 7 days pre/post earnings
  • Fresh crossover: Detected on today's close

Holding period: 2-6 weeks | Risk level: Medium

🟢 Buy Signals (2 of 2)

Ranked by RSI (lower RSI = more oversold for buy signals)

# Ticker Company Sector Price Insider MCap
1 BFLY Butterfly Network, Inc. Healthcare $8.27 — $2.2B
2 MET MetLife, Inc. Financial Services $95.78 — $61.6B

🔴 Sell Signals (5 of 18)

# Ticker Company Sector Price Insider MCap
1 AMR Alpha Metallurgical Re... Basic Materials $170.21 — $2.2B
2 APPF AppFolio Inc. Technology $196.97 — $7.0B
3 CBZ CBIZ, Inc. Industrials $54.75 — $2.9B
4 CDE Coeur Mining, Inc. Basic Materials $16.50 — $17.0B
5 CHEF The Chefs' Warehouse, ... Consumer Defensive $111.01 — $4.5B

EMA 10/30 Crossover

Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.

Entry Criteria:

  • Buy: EMA10 crosses above EMA30
  • Sell: EMA10 crosses below EMA30
  • Minimum ADV: $40M (liquidity filter)
  • Earnings buffer: 7 days pre/post earnings
  • Fresh crossover: Detected on today's close

Holding period: 1-4 weeks | Risk level: Medium

🟢 Buy Signals (5 of 18)

Ranked by RSI (lower RSI for buy signals = more oversold)

# Ticker Company Sector Price Insider MCap
1 AFRM Affirm Holdings, Inc. Technology $75.31 — $25.2B
2 BSY Bentley Systems, Incor... Technology $35.15 — $10.3B
3 CEG Constellation Energy C... Utilities $299.59 — $107.6B
4 CLF Cleveland-Cliffs Inc. Basic Materials $12.06 — $6.9B
5 COST Costco Wholesale Corpo... Consumer Defensive $942.25 — $417.9B

🔴 Sell Signals (5 of 26)

# Ticker Company Sector Price Insider MCap
1 BAP Credicorp Ltd. Financial Services $376.11 — $29.9B
2 BBNX Beta Bionics, Inc. Healthcare $18.08 — $813M
3 BELFB Bel Fuse Inc. Technology $246.72 — $3.0B
4 BETA BETA Technologies, Inc. Industrials $20.26 Sell -$1,086,007 $4.5B
5 BGC BGC Group, Inc Financial Services $11.29 — $5.4B

Insider selling (7d): BETA (-$1,086,007)

Field Notes

Sector concentration: Technology (14), Healthcare (12), Basic Materials (10)

Insider selling (7d): BETA (BETA Technologies, Inc., -$1,086,007)

Data coverage: 2.7% insider (7d), 0.0% congressional (30d), 0.0% earnings, 6.8% news (7d)

Vlad's Take

Today's signals: Strong sector concentration in Technology (14 signals) suggests sector-specific rotation.


Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

📢 If you found this useful, a quick like, share, or subscribe keeps EverHint moving forward.